Data / Drug companies / Chain Drug Marketing Association, Inc.
Chain Drug Marketing Association, Inc.: 298 products in the FDA NDC directory, labeler code 83324
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Chain Drug Marketing Association, Inc. (labeler code 83324) lists 298 products in the FDA National Drug Code Directory, covering 148 finished drugs by generic name. By type: 298 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 23, 2026.
The request: Watch Chain Drug Marketing Association, Inc. (FDA labeler code 83324): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 83324
- Products in commercial distribution
- 298
- Packages
- 360
- Finished drugs by generic name
- 148
- Prescription products
- 0
- Over the counter products
- 298
- Flagged as original packager
- 242 of 242 products that carry the flag
- Started marketing in the last 12 months
- 31
- Earliest marketing start
- June 1, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 239 | 80.2% |
| Generic drugs (ANDA) | 50 | 16.8% |
| Other unapproved drugs | 5 | 1.7% |
| Unapproved homeopathic products | 2 | 0.7% |
| New drug applications (NDA) | 2 | 0.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 298 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 43 | 14.4% |
| Tablet | 27 | 9.1% |
| Tablet, coated | 27 | 9.1% |
| Capsule, liquid filled | 21 | 7% |
| Tablet, chewable | 17 | 5.7% |
| Tablet, film coated | 15 | 5% |
| Spray | 14 | 4.7% |
| Cream | 12 | 4% |
| Solution/ drops | 10 | 3.4% |
| Solution | 10 | 3.4% |
| Ointment | 9 | 3% |
| Tablet, delayed release | 9 | 3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Omeprazole | 83324-309 | Capsule, delayed release | Generic drugs (ANDA) | October 23, 2026 |
| Acid Reducer | 83324-287 | Tablet, delayed release | Generic drugs (ANDA) | October 22, 2026 |
| Esomeprazole Magnesium | 83324-328 | Capsule, delayed release | Generic drugs (ANDA) | October 9, 2026 |
| Antacid and antigas | 83324-343 | Liquid | Over the counter monograph drugs | October 1, 2026 |
| QUALITY CHOICE Adult Long-Acting Cough Softgel | 83324-346 | Capsule, liquid filled | Over the counter monograph drugs | September 9, 2026 |
| Antacid and antigas | 83324-345 | Suspension | Over the counter monograph drugs | September 1, 2026 |
| Magnesium Citrate | 83324-043 | Liquid | Over the counter monograph drugs | August 28, 2026 |
| Quality Choice Effervescent Antacid and Pain Relief | 83324-084 | Tablet, effervescent | Over the counter monograph drugs | August 21, 2026 |
| Salicylic acid | 83324-182 | Gel | Over the counter monograph drugs | July 22, 2026 |
| Gas Relief | 83324-352 | Capsule | Over the counter monograph drugs | July 21, 2026 |
| Fluticasone Propionate | 83324-294 | Spray, metered | Generic drugs (ANDA) | July 2, 2026 |
| Quality Choice Natural White | 83324-291 | Paste | Over the counter monograph drugs | July 1, 2026 |
| Ibuprofen mini dye free | 83324-204 | Capsule, liquid filled | Generic drugs (ANDA) | June 30, 2026 |
| Quality Choice Effervescent Cold Relief - Orange | 83324-240 | Tablet, effervescent | Over the counter monograph drugs | June 5, 2026 |
| Quality Choice Earwax Removal Drops Earwax Removal Aid | 83324-283 | Solution/ drops | Over the counter monograph drugs | June 1, 2026 |
| Quality Choice Earwax Removal Kit Earwax Removal Aid and Bulb | 83324-282 | Kit | Over the counter monograph drugs | June 1, 2026 |
| Quality Choice Effervescent Antacid and Pain Relief - Extra Strength | 83324-241 | Tablet, effervescent | Over the counter monograph drugs | May 12, 2026 |
| Quality Choice Effervescent Cold Relief - Plus | 83324-239 | Tablet, effervescent | Over the counter monograph drugs | May 12, 2026 |
| Quality Choice Lidocaine Pain Relief Patch | 83324-257 | Patch | Over the counter monograph drugs | May 1, 2026 |
| Advanced Hand Sanitizer with Aloe | 83324-119 | Gel | Over the counter monograph drugs | February 23, 2026 |
| Castor Oil | 83324-055 | Liquid | Over the counter monograph drugs | February 23, 2026 |
| Advanced Hand Sanitizer | 83324-065 | Liquid | Over the counter monograph drugs | February 19, 2026 |
| Flu HBP | 83324-062 | Tablet, film coated | Over the counter monograph drugs | February 17, 2026 |
| Ibuprofen | 83324-210 | Capsule, liquid filled | Generic drugs (ANDA) | December 9, 2025 |
| Quality Choice Urinary Pain Relief | 83324-201 | Tablet | Other unapproved drugs | December 2, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.